Rankings
▼
Calendar
BIIB FY 2019 Earnings — Biogen Inc. Revenue & Financial Results | Market Cap Arena
BIIB
Biogen Inc.
$28B
FY 2019 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$14.4B
+6.9% YoY
Gross Profit
$12.4B
86.4% margin
Operating Income
$7.0B
49.0% margin
Net Income
$5.9B
41.0% margin
EPS (Diluted)
$31.42
Cash Flow
Operating Cash Flow
$7.1B
Free Cash Flow
$6.6B
Stock-Based Comp.
$182M
Balance Sheet
Total Assets
$27.2B
Total Liabilities
$13.9B
Stockholders' Equity
$13.3B
Cash & Equivalents
$2.9B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$14.4B
$13.5B
+6.9%
Gross Profit
$12.4B
$11.6B
+6.8%
Operating Income
$7.0B
$5.9B
+19.6%
Net Income
$5.9B
$4.4B
+32.9%
← Q4 2018
All Quarters
Q1 2019 →